We are live on ! Find out more
GMDA

Gamida Cell Ltd. Ordinary Shares
GMDA

Delisted

GMDA was delisted on the 5th of April, 2024.

Back to rankings

59 hedge funds and large institutions have $84M invested in Gamida Cell Ltd. Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more capital invested

Capital invested by funds: $45.8M → $84M (+$38.2M)

43% more call options, than puts

Call options by funds: $827K | Put options by funds: $577K

6% less funds holding

Funds holding: 63 → 59 (-4)

17% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 18

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

Holders
59
Holders Change
-4
Holders Change %
-6.35%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
15
Reduced
18
Closed
9
Calls
$827K
Puts
$577K
Net Calls
+$250K
Net Calls Change
+$298K

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$2.56M
2
HCM
Highbridge Capital Management
New York
+$679K
3
AIM
ARK Investment Management
Florida
+$343K
4
JP Morgan Chase
JP Morgan Chase
New York
+$278K
5
Marshall Wace
Marshall Wace
United Kingdom
+$264K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$1.55M
2
Renaissance Technologies
Renaissance Technologies
New York
-$749K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$379K
4
LCS
Levin Capital Strategies
New York
-$168K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$144K
Name Holding Trade Value Shares
Change 		Change in
Stake
ML
26
McAdam LLC
Pennsylvania
$106K – – –
Goldman Sachs
27
Goldman Sachs
New York
$89K -$56.8K -16,938 -44%
LCS
28
Levin Capital Strategies
New York
$83K -$168K -50,000 -71%
GIM
29
Guild Investment Management
California
$75K – – –
Bank of America
30
Bank of America
North Carolina
$63K +$43K +12,833 +539%
Stifel Financial
31
Stifel Financial
Missouri
$60K – – –
Two Sigma Advisers
32
Two Sigma Advisers
New York
$51K -$75.4K -22,500 -65%
PPA
33
Parametric Portfolio Associates
Washington
$51K -$66.4K -19,822 -62%
Creative Planning
34
Creative Planning
Kansas
$50K +$40.2K +11,988 New
PFO
35
Pathstone Family Office
New Jersey
$47K -$1.41K -420 -4%
1CM
36
1492 Capital Management
Wisconsin
$42K – – –
Group One Trading
37
Group One Trading
Illinois
$40K -$42.5K -12,665 -57%
IFAM
38
Institutional & Family Asset Management
Colorado
$29K – – –
Wells Fargo
39
Wells Fargo
California
$25K +$8.71K +2,600 +72%
Belvedere Trading
40
Belvedere Trading
Illinois
$23K +$24.3K +7,251 New
MCM
41
MV Capital Management
Maryland
$20K – – –
TRCT
42
Tower Research Capital (TRC)
New York
$18K -$13.1K -3,894 -47%
UBS Group
43
UBS Group
Switzerland
$16K +$13K +3,882 New
TWC
44
TD Waterhouse Canada
Ontario, Canada
$16K +$13.4K +4,000 New
US Bancorp
45
US Bancorp
Minnesota
$8K +$2.68K +800 +66%
Citigroup
46
Citigroup
New York
$5K -$1.76K -524 -29%
HIIFS
47
Harel Insurance Investments & Financial Services
Israel
$5K -$419 -125 -9%
QT
48
Quantbot Technologies
New York
$5K +$4.36K +1,300 New
Osaic Holdings
49
Osaic Holdings
Arizona
$4K -$17.2K -5,134 -85%
AP
50
Atwood & Palmer
Missouri
$4K – – –
1
2
3

GMDA Hedge Fund Activity: Q1 2022 in Review

59 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Gamida Cell Ltd. Ordinary Shares (GMDA) for Q1 2022, worth a combined $84M — up 83% from $45.8M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of GMDA and 6 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 15 added.

The largest buyer was Federated Hermes, adding an estimated $2.56M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $1.55M sold.

  • 59 institutional investors held Gamida Cell Ltd. Ordinary Shares (GMDA) as of Q1 2022, down from 63 in Q4 2021.
  • Funds reported $84M of Gamida Cell Ltd. Ordinary Shares stock for Q1 2022, up 83% quarter-over-quarter.
  • 6 funds opened new Gamida Cell Ltd. Ordinary Shares positions in Q1 2022 and 9 closed out, a net change of -3 holders.
  • The largest Gamida Cell Ltd. Ordinary Shares buyer in Q1 2022 was Federated Hermes, an estimated $2.56M added.
  • The largest Gamida Cell Ltd. Ordinary Shares seller in Q1 2022 was Baker Bros. Advisors, an estimated $1.55M sold.

Based on aggregated 13F filings for Q1 2022.